{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:43:41Z","timestamp":1783410221551,"version":"3.54.6"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2662022XXYJ007"],"award-info":[{"award-number":["2662022XXYJ007"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2662022JC004"],"award-info":[{"award-number":["2662022JC004"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>It is difficult to generate new molecules with desirable bioactivity through ligand-based de novo drug design, and receptor-based de novo drug design is constrained by disease target information availability. The combination of artificial intelligence and phenotype-based de novo drug design can generate new bioactive molecules, independent from disease target information. Gene expression profiles can be used to characterize biological phenotypes. The Transformer model can be utilized to capture the associations between gene expression profiles and molecular structures due to its remarkable ability in processing contextual information.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We propose TransGEM (Transformer-based model from gene expression to molecules), which is a phenotype-based de novo drug design model. A specialized gene expression encoder is used to embed gene expression difference values between diseased cell lines and their corresponding normal tissue cells into TransGEM model. The results demonstrate that the TransGEM model can generate molecules with desirable evaluation metrics and property distributions. Case studies illustrate that TransGEM model can generate structurally novel molecules with good binding affinity to disease target proteins. The majority of genes with high attention scores obtained from TransGEM model are associated with the onset of the disease, indicating the potential of these genes as disease targets. Therefore, this study provides a new paradigm for de novo drug design, and it will promote phenotype-based drug discovery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availability and implementation<\/jats:title>\n                  <jats:p>The code is available at https:\/\/github.com\/hzauzqy\/TransGEM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btae189","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T02:20:29Z","timestamp":1713406829000},"source":"Crossref","is-referenced-by-count":14,"title":["TransGEM: a molecule generation model based on Transformer with gene expression data"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3086-9586","authenticated-orcid":false,"given":"Yanguang","family":"Liu","sequence":"first","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Yu","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Duan","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Cheng","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ruan","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-4401","authenticated-orcid":false,"given":"Hongyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-590X","authenticated-orcid":false,"given":"Qingye","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University , Wuhan 430070, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"2024050903012402200_btae189-B1","author":"Benhenda","year":"2017"},{"key":"2024050903012402200_btae189-B2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat Chem"},{"key":"2024050903012402200_btae189-B3","doi-asserted-by":"crossref","first-page":"102269","DOI":"10.1016\/j.isci.2021.102269","article-title":"PaccMannRL: de novo generation of hit-like anticancer molecules from transcriptomic data via reinforcement learning","volume":"24","author":"Born","year":"2021","journal-title":"iScience"},{"key":"2024050903012402200_btae189-B4","doi-asserted-by":"crossref","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","article-title":"RCSB protein data bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences","volume":"49","author":"Burley","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2024050903012402200_btae189-B5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2019.06.004","article-title":"Advancing drug discovery via artificial intelligence","volume":"40","author":"Chan","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"2024050903012402200_btae189-B6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/30.1.412","article-title":"TTD: therapeutic target database","volume":"30","author":"Chen","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2024050903012402200_btae189-B7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2105-15-79","article-title":"The characteristic direction: a geometrical approach to identify differentially expressed genes","volume":"15","author":"Clark","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"2024050903012402200_btae189-B8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol Biol"},{"key":"2024050903012402200_btae189-B9","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1021\/acs.jcim.2c01301","article-title":"Gex2SGen: designing drug-like molecules from desired gene expression signatures","volume":"63","author":"Das","year":"2023","journal-title":"J Chem Inf Model"},{"key":"2024050903012402200_btae189-B10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40265-015-0345-6","article-title":"Olaparib: first global approval","volume":"75","author":"Deeks","year":"2015","journal-title":"Drugs"},{"key":"2024050903012402200_btae189-B11","first-page":"1","article-title":"Role of PARP-1 in prostate cancer","volume":"3","author":"Deshmukh","year":"2015","journal-title":"Am J Clin Exp Urol"},{"key":"2024050903012402200_btae189-B12","doi-asserted-by":"crossref","first-page":"6616","DOI":"10.1158\/1078-0432.CCR-17-0310","article-title":"131I-labeled anti-HER2 camelid sdAb as a theranostic tool in cancer treatment","volume":"23","author":"D\u2019Huyvetter","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2024050903012402200_btae189-B13","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1038\/npjsba.2016.15","article-title":"L1000CDS2: LINCS L1000 characteristic direction signatures search engine","volume":"2","author":"Duan","year":"2016","journal-title":"NPJ Syst Biol Appl"},{"key":"2024050903012402200_btae189-B14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-2946-1-8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J Cheminform"},{"key":"2024050903012402200_btae189-B15","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.3390\/ijms20205168","article-title":"Emerging roles of DDB2 in cancer","volume":"20","author":"Gilson","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2024050903012402200_btae189-B16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1039\/D1MD00074H","article-title":"De novo molecular drug design benchmarking","volume":"12","author":"Grant","year":"2021","journal-title":"RSC Med Chem"},{"key":"2024050903012402200_btae189-B17","doi-asserted-by":"crossref","first-page":"14573","DOI":"10.1073\/pnas.1908547116","article-title":"Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function","volume":"116","author":"Gui","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024050903012402200_btae189-B18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1021\/ml400292s","article-title":"Evaluation and structural basis for the inhibition of Tankyrases by PARP inhibitors","volume":"5","author":"Haikarainen","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"2024050903012402200_btae189-B19","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/17460441.2021.1909567","article-title":"Artificial intelligence in drug discovery: recent advances and future perspectives","volume":"16","author":"Jim\u00e9nez-Luna","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"2024050903012402200_btae189-B20","doi-asserted-by":"crossref","first-page":"045024","DOI":"10.1088\/2632-2153\/aba947","article-title":"Self-referencing embedded strings (SELFIES): a 100% robust molecular string representation","volume":"1","author":"Krenn","year":"2020","journal-title":"Mach Learn Sci Technol"},{"key":"2024050903012402200_btae189-B21","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"2024050903012402200_btae189-B22","doi-asserted-by":"crossref","first-page":"22359","DOI":"10.18632\/oncotarget.25009","article-title":"Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker","volume":"9","author":"Levin","year":"2018","journal-title":"Oncotarget"},{"key":"2024050903012402200_btae189-B23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/molecules25061375","article-title":"A review on applications of computational methods in drug screening and design","volume":"25","author":"Lin","year":"2020","journal-title":"Molecules"},{"key":"2024050903012402200_btae189-B24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2017.12.008","article-title":"SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis","volume":"416","author":"Liu","year":"2018","journal-title":"Cancer Lett"},{"key":"2024050903012402200_btae189-B25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbrc.2018.09.160","article-title":"Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1","volume":"505","author":"Long","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2024050903012402200_btae189-B26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41467-019-13807-w","article-title":"De novo generation of hit-like molecules from gene expression signatures using artificial intelligence","volume":"11","author":"M\u00e9ndez-Lucio","year":"2020","journal-title":"Nat Commun"},{"key":"2024050903012402200_btae189-B27","doi-asserted-by":"crossref","first-page":"e54166","DOI":"10.7554\/eLife.54166","article-title":"Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis","volume":"9","author":"Nassar","year":"2020","journal-title":"Elife"},{"key":"2024050903012402200_btae189-B28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13321-021-00498-z","article-title":"Diversity oriented deep reinforcement learning for targeted molecule generation","volume":"13","author":"Pereira","year":"2021","journal-title":"J Cheminform"},{"key":"2024050903012402200_btae189-B29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s42256-020-00285-9","article-title":"A deep learning framework for high-throughput mechanism-driven phenotype compound screening and its application to COVID-19 drug repurposing","volume":"3","author":"Pham","year":"2021","journal-title":"Nat Mach Intell"},{"key":"2024050903012402200_btae189-B30","first-page":"720","author":"Pham","year":"2022"},{"key":"2024050903012402200_btae189-B31","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1021\/acs.jcim.3c00355","article-title":"De novo design of molecules with multiaction potential from differential gene expression using variational autoencoder","volume":"63","author":"Pravalphruekul","year":"2023","journal-title":"J Chem Inf Model"},{"key":"2024050903012402200_btae189-B32","doi-asserted-by":"crossref","first-page":"105292","DOI":"10.1016\/j.compbiomed.2022.105292","article-title":"De novo protein folding on computers. Benefits and challenges","volume":"143","author":"Robson","year":"2022","journal-title":"Comput Biol Med"},{"key":"2024050903012402200_btae189-B33","doi-asserted-by":"crossref","first-page":"100251","DOI":"10.1074\/jbc.RA120.016573","article-title":"Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1","volume":"296","author":"Ryan","year":"2021","journal-title":"J Biol Chem"},{"key":"2024050903012402200_btae189-B34","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1021\/acs.jmedchem.2c01737","article-title":"Is target-based drug discovery efficient? Discovery and \u201coff-target\u201d mechanisms of all drugs","volume":"66","author":"Sadri","year":"2023","journal-title":"J Med Chem"},{"key":"2024050903012402200_btae189-B35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fphar.2020.00269","article-title":"Molecular generation for desired transcriptome changes with adversarial autoencoders","volume":"11","author":"Shayakhmetov","year":"2020","journal-title":"Front Pharmacol"},{"key":"2024050903012402200_btae189-B36","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2024050903012402200_btae189-B37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/0008-5472.CAN-08-3633","article-title":"Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth","volume":"69","author":"Takayama","year":"2009","journal-title":"Cancer Res"},{"key":"2024050903012402200_btae189-B38","first-page":"A68","article-title":"The cancer genome atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"2024050903012402200_btae189-B39","author":"Vaswani","year":"2017"},{"key":"2024050903012402200_btae189-B40","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-022-00472-w","article-title":"Phenotypic drug discovery: recent successes, lessons learned and new directions","volume":"21","author":"Vincent","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"2024050903012402200_btae189-B41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pros.21078","article-title":"Immunosuppressive CD14+HLA-DRlow\/\u2212 monocytes in prostate cancer","volume":"70","author":"Vuk-Pavlovi\u0107","year":"2010","journal-title":"Prostate"},{"key":"2024050903012402200_btae189-B42","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1039\/C9CP06303J","article-title":"Combined strategies in structure-based virtual screening","volume":"22","author":"Wang","year":"2020","journal-title":"Phys Chem Phys"},{"key":"2024050903012402200_btae189-B43","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1021\/acs.jcim.0c01494","article-title":"De novo molecule design through the molecular generative model conditioned by 3D information of protein binding sites","volume":"61","author":"Xu","year":"2021","journal-title":"J Chem Inf Model"},{"key":"2024050903012402200_btae189-B44","doi-asserted-by":"crossref","first-page":"101642","DOI":"10.1016\/j.tranon.2023.101642","article-title":"HER2 as a potential therapeutic target on quiescent prostate cancer cells","volume":"31","author":"Yumoto","year":"2023","journal-title":"Transl Oncol"},{"key":"2024050903012402200_btae189-B45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11306-022-01968-7","article-title":"Multi-omics profiling of PC-3 cells reveals bufadienolides-induced lipid metabolic remodeling by regulating long-chain lipids synthesis and hydrolysis","volume":"19","author":"Zhang","year":"2023","journal-title":"Metabolomics"},{"key":"2024050903012402200_btae189-B46","doi-asserted-by":"crossref","first-page":"2101458","DOI":"10.1002\/advs.202101458","article-title":"Co-Targeting Plk1 and DNMT3a in advanced prostate cancer","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv Sci"},{"key":"2024050903012402200_btae189-B47","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-pharmtox-010919-023324","article-title":"Big data and artificial intelligence modeling for drug discovery","volume":"60","author":"Zhu","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btae189\/57262444\/btae189.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/40\/5\/btae189\/57456054\/btae189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/40\/5\/btae189\/57456054\/btae189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T03:02:00Z","timestamp":1715223720000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/doi\/10.1093\/bioinformatics\/btae189\/7649318"}},"subtitle":[],"editor":[{"given":"Macha","family":"Nikolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btae189","relation":{},"ISSN":["1367-4811"],"issn-type":[{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5,1]]},"published":{"date-parts":[[2024,4,17]]},"article-number":"btae189"}}